Kallikreins, antagonists & inhibitors
- Name
- Kallikreins, antagonists & inhibitors
- Accession Number
- DBCAT001688
- Description
Not Available
- Drugs
Drug Drug Description Ecallantide A kallikrein inhibitor used to prevent and treat acute attacks caused by Hereditary Angioedema (HAE). Nafamostat Used as an anticoagulant in patients with disseminative blood vessel coagulation, hemorrhagic lesions, and hemorrhagic tendencies. It prevents blood clot formation during extracorporeal circulation in patients undergoing continuous renal replacement... Kallidinogenase Not Annotated Berotralstat An inhibitor of plasma kallikrein used for prophylaxis of angioedema attacks in patients with hereditary angioedema. - Drugs & Drug Targets
Drug Target Type Ecallantide Plasma kallikrein target Nafamostat Intercellular adhesion molecule 1 target Nafamostat Trypsin-1 target Nafamostat Kallikrein-1 target Nafamostat Prothrombin target Nafamostat Coagulation factor X target Nafamostat Coagulation factor XII target Nafamostat Solute carrier family 22 member 1 transporter Nafamostat Solute carrier family 22 member 2 transporter Berotralstat Cytochrome P450 2D6 enzyme Berotralstat Cytochrome P450 3A4 enzyme Berotralstat P-glycoprotein 1 transporter Berotralstat ATP-binding cassette sub-family G member 2 transporter Berotralstat Plasma kallikrein target